Udom Chantharaksri

483 total citations
29 papers, 399 citations indexed

About

Udom Chantharaksri is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Udom Chantharaksri has authored 29 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 6 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Udom Chantharaksri's work include Hemoglobinopathies and Related Disorders (14 papers), Iron Metabolism and Disorders (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Udom Chantharaksri is often cited by papers focused on Hemoglobinopathies and Related Disorders (14 papers), Iron Metabolism and Disorders (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Udom Chantharaksri collaborates with scholars based in Thailand, United States and Singapore. Udom Chantharaksri's co-authors include Suthat Fucharoen, Noppawan Phumala Morales, Piyamitr Sritara, Sansanee C. Chaiyaroj, Anna‐Riitta Fuchs, Supeenun Unchern, Pensri Pootrakul, Rachanee Udomsangpetch, Nathawut Sibmooh and Prapin Wilairat and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Biochemical Pharmacology and Biology of Reproduction.

In The Last Decade

Udom Chantharaksri

28 papers receiving 383 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Udom Chantharaksri 119 86 81 63 51 29 399
Yan Shen 55 0.5× 159 1.8× 122 1.5× 28 0.4× 93 1.8× 41 654
C. Sappey 28 0.2× 148 1.7× 40 0.5× 43 0.7× 31 0.6× 7 455
F Weber 49 0.4× 130 1.5× 71 0.9× 17 0.3× 18 0.4× 29 755
Philip D. Zieve 32 0.3× 116 1.3× 119 1.5× 28 0.4× 25 0.5× 24 417
J. Pütter 114 1.0× 105 1.2× 19 0.2× 50 0.8× 25 0.5× 37 443
Antonella Zampolli 41 0.3× 121 1.4× 109 1.3× 12 0.2× 110 2.2× 19 619
A. William Shafer 23 0.2× 115 1.3× 37 0.5× 90 1.4× 68 1.3× 21 574
Fabrizió Franchi 26 0.2× 102 1.2× 37 0.5× 20 0.3× 9 0.2× 44 463
Justin M. Cole 92 0.8× 230 2.7× 43 0.5× 16 0.3× 8 0.2× 18 628
Martina Canestraro 17 0.1× 217 2.5× 60 0.7× 23 0.4× 14 0.3× 16 415

Countries citing papers authored by Udom Chantharaksri

Since Specialization
Citations

This map shows the geographic impact of Udom Chantharaksri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udom Chantharaksri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udom Chantharaksri more than expected).

Fields of papers citing papers by Udom Chantharaksri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Udom Chantharaksri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udom Chantharaksri. The network helps show where Udom Chantharaksri may publish in the future.

Co-authorship network of co-authors of Udom Chantharaksri

This figure shows the co-authorship network connecting the top 25 collaborators of Udom Chantharaksri. A scholar is included among the top collaborators of Udom Chantharaksri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Udom Chantharaksri. Udom Chantharaksri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilairat, Prapin, et al.. (2010). Pharmacokinetics of Deferiprone in Patients with β-Thalassaemia. Clinical Pharmacokinetics. 50(1). 41–50. 14 indexed citations
2.
Chantharaksri, Udom, et al.. (2010). Atorvastatin affects TLR4 clustering via lipid raft modulation. International Immunopharmacology. 10(8). 892–899. 35 indexed citations
3.
Morales, Noppawan Phumala, et al.. (2009). Bioequivalence study of a film-coated tablet of deferiprone in healthy Thai volunteers. International Journal of Clinical Pharmacology and Therapeutics. 47(5). 358–364. 6 indexed citations
4.
Morales, Noppawan Phumala, et al.. (2009). Pharmaco/ferrokinetic-related pro-oxidant activity of deferiprone inβ-thalassemia. Free Radical Research. 43(5). 485–491. 11 indexed citations
5.
Svasti, Saovaros, et al.. (2008). UGT1A6 genotype‐related pharmacokinetics of deferiprone (L1) in healthy volunteers. British Journal of Clinical Pharmacology. 65(6). 908–916. 30 indexed citations
6.
Morales, Noppawan Phumala, et al.. (2007). Association between promoter and coding region mutations of UDP‐glucuronosyltransferase 1A1 and β‐thalassemia/Hb E with cholelithiasis. European Journal Of Haematology. 80(4). 351–355. 6 indexed citations
7.
Morales, Noppawan Phumala, et al.. (2007). Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of β-thalassemia/hemoglobin E patients. Clinical Chemistry and Laboratory Medicine (CCLM). 45(7). 884–9. 9 indexed citations
8.
Luechapudiporn, Rataya, Noppawan Phumala Morales, Suthat Fucharoen, & Udom Chantharaksri. (2006). The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in β-thalassemia/Hb E. Clinical Chemistry and Laboratory Medicine (CCLM). 44(5). 13 indexed citations
9.
Morales, Noppawan Phumala, et al.. (2006). Effects of Combined UDP-Glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on Paracetamol Pharmacokinetics in β-Thalassemia/HbE. Pharmacology. 79(2). 97–103. 25 indexed citations
10.
Howard, Thad A., Pornpan Sirankapracha, Noppawan Phumala Morales, et al.. (2006). A pharmacokinetic study of paracetamol in Thai β-thalassemia/HbE patients. European Journal of Clinical Pharmacology. 62(9). 743–748. 3 indexed citations
11.
Morales, Noppawan Phumala, et al.. (2006). Lipid fluidity at different regions in LDL and HDL of β-thalassemia/Hb E patients. Biochemical and Biophysical Research Communications. 350(3). 698–703. 12 indexed citations
12.
Unchern, Supeenun, et al.. (2004). The Pharmacokinetics Study of Paracetamol And Its Metabolites in Thalassemic Patients. 26(1). 67. 1 indexed citations
13.
Unchern, Supeenun, et al.. (2003). The effects of vitamin E on platelet activity in β‐thalassaemia patients. British Journal of Haematology. 123(4). 738–744. 27 indexed citations
14.
Porasuphatana, Supatra, et al.. (2003). Hemin: A Possible Cause of Oxidative Stress in Blood Circulation of β-Thalassemia/Hemoglobin E Disease. Free Radical Research. 37(2). 129–135. 32 indexed citations
15.
Phivthong‐ngam, Laddawal, et al.. (2003). Improvement of vascular function by chronic administration of a cyclo‐oxygenase inhibitor in cholesterol‐fed rabbits. Clinical and Experimental Pharmacology and Physiology. 30(5-6). 405–412. 11 indexed citations
16.
Sibmooh, Nathawut, Rachanee Udomsangpetch, Anake Kijjoa, Udom Chantharaksri, & Samlee Mankhetkorn. (2001). Redox Reaction of Artemisinin with Ferrous and Ferric Ions in Aqueous Buffer.. Chemical and Pharmaceutical Bulletin. 49(12). 1541–1546. 29 indexed citations
17.
Sibmooh, Nathawut, et al.. (2000). Effect of Artemisinin on Lipid Peroxidation and Fluidity of the Erythrocyte Membrane in Malaria.. Biological and Pharmaceutical Bulletin. 23(11). 1275–1280. 22 indexed citations
18.
Chantharaksri, Udom, et al.. (1992). Pathogenesis of hypoxemia.. PubMed. 23 Suppl 2. 32–5. 6 indexed citations
19.
Fuchs, Anna‐Riitta & Udom Chantharaksri. (1981). Prostaglandin F2α Regulation of LH-Stimulated Testosterone Production in Rat Testis1. Biology of Reproduction. 25(3). 492–501. 12 indexed citations
20.
Fuchs, Anna‐Riitta, et al.. (1976). The effect of indomethacin on uterine contractility and luteal regression in pregnant rats at term. Reproduction. 48(2). 331–340. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026